Tag: ASPECTS

rapidAI CADx approval

Rapid ASPECTS receives CADx clearance from the FDA

RapidAI has announced that Rapid ASPECTS has received US Food and Drug Administration (FDA) clearance as the first neuroimaging analysis device in the CADx (computer-assisted...
Osama Zaidat low ASPECTS thrombectomy

Thrombectomy fails to find a benefit in the older population with...

A low Alberta stroke program early CT score (ASPECTS) of 4–5 has been deemed the threshold for mechanical thrombectomy, with no benefit elicited in...

SNIS 2019: It is “almost unethical” not to broaden thrombectomy inclusion...

Donald Frei (Denver, USA) talks to BLearning at SNIS 2019 (22–25 July, Miami, USA) to discuss recent data from the cohort of thrombectomy trials which has shown...